| Literature DB >> 31944824 |
F Avraham Dilmanian1,2,3,4, Bhanu P Venkatesulu5, Narayan Sahoo6, Xiaodong Wu7,8, Jessica R Nassimi1, Steven Herchko9, Jiade Lu8, Bilikere S Dwarakanath8, John G Eley10, Sunil Krishnan9.
Abstract
Proton minibeam therapy (PMBT) is a form of spatially fractionated radiotherapy wherein broad beam radiation is replaced with segmented minibeams-either parallel, planar minibeam arrays generated by a multislit collimator or scanned pencil beams that converge laterally at depth to create a uniform dose layer at the tumor. By doing so, the spatial pattern of entrance dose is considerably modified while still maintaining tumor dose and efficacy. Recent studies using computational modeling, phantom experiments, in vitro and in vivo preclinical models, and early clinical feasibility assessments suggest that unique physical and biological attributes of PMBT can be exploited for future clinical benefit. We outline some of the guiding principle of PMBT in this concise overview of this emerging area of preclinical and clinical research inquiry.Entities:
Mesh:
Year: 2020 PMID: 31944824 PMCID: PMC7066973 DOI: 10.1259/bjr.20190332
Source DB: PubMed Journal: Br J Radiol ISSN: 0007-1285 Impact factor: 3.039